Live Reaction

EURETINA Innovation Spotlight (EIS) Kicks Off Vienna Congress in Style

The 4th annual EURETINA Innovation Spotlight (EIS) held on Wednesday afternoon proved again that the programme is a rich educational opportunity for all attendees and a valuable forum for networking and collaboration. Therefore, it is easy to understand why the EIS has become a not-to-be-missed event for physicians, researchers, and industry representatives attending the EURETINA Congress. 

EURETINA Innovation Spotlight (EIS) Kicks Off Vienna Congress in Style Read More »

AI in Medicines Development: EMA Shares Progress, Risks, and Regulatory Roadmap

At the beginning of her keynote address on Artificial Intelligence (AI) in Medicines Development: Perspective From an EU Medicines Regulator, Jane Moseley, Senior Scientific Officer at the European Medicines Agency (EMA) said she would be addressing three key questions: Where do we want to get to with AI in medicines development?; Where are we now?; and How are we going to get there?

AI in Medicines Development: EMA Shares Progress, Risks, and Regulatory Roadmap Read More »

Highlights of the Week: from AMD and imaging to myopia, tumours, uveitis and AI

The EURETINA congress closed with a ‘Highlights of the week’ session, chaired by Anat Loewenstein, Martin Zinkernagel and Nicole Eter. The programme was organised in three sections with panel input from Tunde Peto and Edoardo Midena (Section 1), Aude Coutourier, Grazia Pertile and Heinrich Heimann (Section 2), and Bahram Bodaghi with Heinrich Heimann (Section 3). Below, key items are summarised with the original session noted, along with a brief synopsis as to why they were included in the highlights package. 

A reminder – all of these session are available to view On Demand for registered attendees until the end of the year. 

Highlights of the Week: from AMD and imaging to myopia, tumours, uveitis and AI Read More »